Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GPR176-DT (GPR176 divergent transcript) is an uncharacterized non-coding RNA locus located near the GPR176 gene on human chromosome 15. "Divergent transcripts" (DTs) are often annotated for lncRNAs or non-coding RNAs transcribed in the opposite direction from a nearby protein-coding gene. GPR176-DT is not a protein, nor is it a receptor, enzyme, transporter, or classical therapeutic target. It should not be confused with GPR176 (G protein-coupled receptor 176), which is a seven-transmembrane GPCR implicated in circadian rhythm regulation in the mouse hypothalamus and cancer cell transcriptional response[1][3][5][6][7]. No functional, disease, or drug interaction data for GPR176-DT are currently available.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GPR176 divergent transcript (GPR176-DT).